Madrigal Pharmaceuticals

Madrigal CEO

Biotech

‘It’s making a difference’: Madrigal CEO talks MASH dealmaking

“We want anything that makes sense mechanistically or has proven already to have an effect on MASH,” CEO Bill Sibold told Fierce in an interview.

Will Maddox Aug 3, 2026 8:00am

Liver

Madrigal boosts MASH pipeline with $1B biobucks Arrowhead deal

May 5, 2026 10:40am

Lifeline

Midsize biotechs form coalition to fight against MFN policy

Feb 25, 2026 1:05pm

liver

Madrigal pens $4.4B deal for siRNA drugs in fresh Rezdiffra play

Feb 11, 2026 7:40am

liver

Madrigal pays Pfizer $50M for MASH drug with combo potential

Jan 9, 2026 10:50am

ChatGPT said Low-poly magenta liver model centered on a pale blue background patterned with sketchy dollar signs suggestin

Fierce Pharma

Big Pharma bets big on MASH with a new combo playbook

Oct 17, 2025 9:30am